HMOX1 and acute respiratory distress syndrome: In addition to lung development, roxadustat can relieve airway inflammation and protect against acute lung injury (ALI) by increasing heme oxygenase-1 (HO-1) expression and decreasing tumor necrosis factor-α and interleukin-1β production [62].